Discontinued — last reported Q3 '25
Royal Gold Equity Method Investments increased by 4.5% to $314.28M in Q1 2026 compared to the prior quarter.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q4 '24 | Q4 '25 | Q1 '26 | |
|---|---|---|---|
| Value | $0.00 | $300.85M | $314.28M |
| QoQ Change | — | — | +4.5% |